Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-15

Clinical Trial Update: Observational Study to Evaluate the Safety and Efficacy of Levemir® in Type 2 Diabetes

View source ↗

Summary

Observational study evaluating safety and efficacy of Levemir (insulin detemir) in Type 2 diabetes; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levemir (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Status: COMPLETED